Google
PLSE — PULSE BIOSCIENCES INC (Healthcare >> Medical Instruments & Supplies)
PLSE FAQ
What is PLSE's ROE?
PULSE BIOSCIENCES INC reports a Return on Equity (ROE) of -112.47%.
What is PLSE's dividend yield?
PULSE BIOSCIENCES INC offers a dividend yield of 0.00%.
What is PLSE's Deepscope Quality Score?
Deepscope rates PLSE's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PLSE?
Deepscope's AI Timing Score for PLSE is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PLSE belong to?
PULSE BIOSCIENCES INC is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.
|
USD 25.33
Price
-1.61
(-5.98%)
Day Change
|
|
|---|
PLSE, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 25.33 |
| PBV / Sector |
26.44 / 4.41
|
| Earning Per Share | -1.08 |
| PE / Sector |
N/A / 36.90
|
| PEG or PE/Growth / Sector |
N/A / -0.97
|
| Average 1M Daily Value |
9.79 M
|
| Average 1W Daily Value |
8.42 M
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:06 |
| Symbol | PLSE |
| Name | PULSE BIOSCIENCES INC |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 69.21 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,753.08 / 16,249.68 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 601 Brickell Key Drive, Miami, FL, United States, 33131
Phone: 510 906 4600
Website: https://www.pulsebiosciences.com
Employees: 116
Description: Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
